Bénédicte Nobile, PharmD, PhD | Psychiatrist.com

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.

Bénédicte Nobile, Philippe Courtet

Possible Suicidal Risk With Daridorexant

Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...

Bénédicte Nobile, Emilie Olié, Philippe Courtet

Letter to the Editor

The Antisuicidal Effect of Esketamine Should Be Further Investigated

September 22, 2020

In this letter to the editor, Olié and colleagues comment on a recent JCP article by Fu et al.

Emilie Olié, Bénédicte Nobile, Philippe Courtet

Commentary

Inclusion of Suicidal Individuals in Research Studies

May 12, 2020

This commentary discusses a recent report by Iltis and colleagues.

Philippe Courtet, Bénédicte Nobile